Latham & Watkins represent the underwriters Leerink Partners LLC; Piper Sandler & Co.; Guggenheim Securities, LLC; Wells Fargo Securities, LLC; LifeSci Capital LLC. Immunovant, Inc. (Nasdaq:...
Immunovant’s US$450 Million Common Stock Financing
Instacart’s $660 Million Initial Public Offering
Cooley advised Instacart, and Latham & Watkins advised the underwriters. Maplebear Inc. d/b/a Instacart announced the pricing of its initial public offering of 22,000,000 shares of its...
Rocket Pharmaceuticals’ $175 Million Public Offering
K&L Gates advised Rocket, and Latham advised underwriters. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 7,812,500 shares of its common...
TELA Bio’s $45.125 Million Common Stock Public Offering
Goodwin Procter advised TELA Bio, while Latham & Watkins advised the underwriters on the offering. TELA Bio, Inc. has announced the pricing of its previously announced underwritten...
Mastercard’s $1.5 Billion Notes Offerings
Davis Polk advised Mastercard, and Latham & Watkins advised the underwriters on the offering. Mastercard Incorporated announced its SEC-registered debt offering of $750 million aggregate principal...
Ritchie Bros.’s $1.350 Billion Senior Notes Offering
Skadden and Dorsey & Whitney advised Ritchie Bros. Holdings Inc., McCarthy Tétrault advised Ritchie Bros. Auctioneers Incorporated, and Latham & Watkins advised the initial purchasers. Ritchie...
Intellia Therapeutics’ $300 Million Common Stock Offering
Goodwin Procter represented Intellia Therapeutics, while Latham & Watkins LLP represented the underwriter in the offering. Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused...
Rocket Pharmaceuticals’ $100.3 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of...
Immunovant’s $75 Million Common Stock Offering
Cooley represented Immunovant, while Latham & Watkins represented the underwriters in the offering. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for...
VistaJet Malta Finance’s $500 Million Senior Notes Offering
Latham & Watkins represented VistaJet in the offering. VistaJet Malta Finance P.L.C., a public limited liability company organized under Maltese law and XO Management Holding, Inc.,...
VistaJet Malta Finance P.L.C.’s $1 Billion Notes Offering
Latham & Watkins LLP represented VistaJet in the offering. VistaJet Malta Finance P.L.C., a public limited liability company organized under Maltese law and XO Management Holding,...
DigitalOcean’s $1.5 Billion Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. DigitalOcean Holdings, Inc. finalized its offering of US$1.5 billion aggregate principal amount of 0% convertible senior notes...